Inari Medical, Inc. (NARI)
| Market Cap | 5.20B |
| Revenue (ttm) | 139.67M |
| Net Income (ttm) | 13.79M |
| Shares Out | 49.50M |
| EPS (ttm) | 0.27 |
| PE Ratio | 382.93 |
| Forward PE | 10,000.00 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $103.39 |
| Previous Close | $105.05 |
| Change ($) | -1.66 |
| Change (%) | -1.58% |
| Day's Open | 103.53 |
| Day's Range | 101.06 - 104.00 |
| Day's Volume | 283,006 |
| 52-Week Range | 39.55 - 127.42 |
IRVINE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives...
Industry trends could support massive gains for shareholders over the next 10 years.
Even if the bullishness fades, the prospects for these companies have never been better.
The economy is poised to rebound. Many mutual funds are betting big on cyclical stocks.
If you are following the crowd, you might miss these disruptive companies.
As bond yields finally drop and tech stocks climb, the deep learning algorithms at Q.ai have crunched the data to give you today's best short plays.
The clot-removing device maker is nearly perfect, and it's priced like it.
I'd increase my stakes in two small caps that I already own.
IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...
IRVINE, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
How have these big healthcare IPOs been doing?
OptimizeRx and Inari Medical are both crushing the market right now.
IRVINE, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
IRVINE, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives o...
IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives o...
Inari Medical continues to live up to expectations, showing very solid growth and strong margins. I like the business a lot, yet have not initiated a position yet.
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with six IPOs scheduled to raise $3.4 billion in the week ahead. Biotech research product provider Maravai LifeSciences plans...
There's good reason to think these young stocks have bright futures ahead.
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q3 2020 Results - Earnings Call Transcript
IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team will participate at the Canaccord Genuity Virtual MedTech & Diagno...
IRVINE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the third quarter of 2020 after market close on Thurs...
These fast-growing medical device companies could outperform the S&P 500 over the next several years.
IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the liv...
IRVINE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the live...
IRVINE, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives...
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q2 2020 Results - Earnings Call Transcript
Hot IPO stock Inari Medical late Tuesday reported earnings and sales that beat expectations, but in the regular session shares reversed after hitting an all-time high for a third straight day. The post ...
IRVINE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the live...
IRVINE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced the company will be participating in the upcoming Canaccord Genuity 40th Annual Virtual G...
IRVINE, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the second quarter of 2020 after market close on Tu...
Its medical devices offer promising clinical benefits over the competition.
IRVINE, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives...
Shares of Inari Medical Inc. NARI, +114.07% rocketed out of the gate Friday, as they opened for trading at prices that were more than double the initial public offering price.
Inari Medical Inc. increased that number of shares it was selling in its initial public offering, which priced late Thursday above the expected range.
About NARI
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.
| Industry Medical Devices | IPO Date May 22, 2020 |
| Stock Exchange NASDAQ | Ticker Symbol NARI |
Analyst Forecasts
According to 6 analysts, the average rating for Inari Medical stock is "Buy." The 12-month stock price forecast is 127.67, which is an increase of 23.48% from the latest price.